Sentence examples for molecular tests based from inspiring English sources

Sensitive molecular tests based on PCR have been developed for this species, but they have limitations, including the need for expensive thermal cycling equipment, and complex DNA extraction procedures.

Using sequences of the cytochrome b region of mitochondrial DNA, two molecular tests based on species-specific primers (test 1) and restriction sites generating species-specific profiles (test 2), were designed and evaluated for species identification on a large number of karyotypically or electrophoretically unambiguously determined individuals.

As the molecular mechanisms of resistance of H. pylori are well characterized, determination of these genes with molecular tests based on H. pylori DNA in feces seems feasible [ 13].

A molecular test based on DNA amplification by PCR was developed for the detection of bacteriophages of Bacteroides fragilis strain HSP40 in the environment.

Xpert MTB/RIF assay is an automatic molecular test based on seminested real-time PCR and molecular beacon technology targeting the rpoB gene.

Thus, a molecular test based on blood monocyte cells may serve as an effective diagnosis tool for an early stage of atherosclerosis.

Similar to other reports [ 16- 18] we confirm that a commercial molecular test based on the amplification of a fragment spanning SCC mec and orfX has low PPVs in a low prevalence setting.

We identified the morphological appearance of single CTCs suitable for diagnostic molecular profiling and describe a simple molecular test based on genome integrity that predicts the outcome of all molecular assays tested, including targeted sequencing, assessment of gene amplification or genome-wide studies.

Clinical laboratories are naturally striving to implement molecular diagnostic tests based on genomic methods such as massively parallel sequencing in order to provide genetic diagnosis at the genome scale, while leveraging the parallel processing and nanoscale architecture inherent in these technologies to consolidate costs and maintain turnaround times.

One can envisage the use of a molecular genetic test based on the consistent loss of 9p in cells detected in the urine for such screening purposes.

In BMT recipients, tests based on molecular techniques appeared to be superior compared to antigenemia.